GB202101935D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB202101935D0
GB202101935D0 GBGB2101935.1A GB202101935A GB202101935D0 GB 202101935 D0 GB202101935 D0 GB 202101935D0 GB 202101935 A GB202101935 A GB 202101935A GB 202101935 D0 GB202101935 D0 GB 202101935D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2101935.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mission Therapeutics Ltd
Original Assignee
Mission Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mission Therapeutics Ltd filed Critical Mission Therapeutics Ltd
Priority to GBGB2101935.1A priority Critical patent/GB202101935D0/en
Publication of GB202101935D0 publication Critical patent/GB202101935D0/en
Priority to PCT/EP2021/064897 priority patent/WO2021245186A1/en
Priority to AU2021285130A priority patent/AU2021285130A1/en
Priority to CA3185654A priority patent/CA3185654A1/en
Priority to CN202180038498.9A priority patent/CN115698001A/en
Priority to US18/007,641 priority patent/US20230303547A1/en
Priority to IL298710A priority patent/IL298710A/en
Priority to KR1020237000160A priority patent/KR20230019198A/en
Priority to EP21731947.4A priority patent/EP4161920A1/en
Priority to MX2022015254A priority patent/MX2022015254A/en
Priority to BR112022019722A priority patent/BR112022019722A2/en
Priority to JP2022571212A priority patent/JP2023529570A/en
Priority to CONC2022/0017112A priority patent/CO2022017112A2/en
Priority to ZA2022/13866A priority patent/ZA202213866B/en
Ceased legal-status Critical Current

Links

GBGB2101935.1A 2020-06-04 2021-02-11 Novel compounds Ceased GB202101935D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB2101935.1A GB202101935D0 (en) 2021-02-11 2021-02-11 Novel compounds
JP2022571212A JP2023529570A (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as USP30 inhibitors
IL298710A IL298710A (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors
EP21731947.4A EP4161920A1 (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors
CA3185654A CA3185654A1 (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors
CN202180038498.9A CN115698001A (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines having activity as USP30 inhibitors
US18/007,641 US20230303547A1 (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors
PCT/EP2021/064897 WO2021245186A1 (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors
KR1020237000160A KR20230019198A (en) 2020-06-04 2021-06-03 N-cyanopyrrolidine with activity as a USP30 inhibitor
AU2021285130A AU2021285130A1 (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as USP30 inhibitors
MX2022015254A MX2022015254A (en) 2020-06-04 2021-06-03 N-cyanopyrrolidines with activity as usp30 inhibitors.
BR112022019722A BR112022019722A2 (en) 2020-06-04 2021-06-03 N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS
CONC2022/0017112A CO2022017112A2 (en) 2020-06-04 2022-11-29 N-cyanopyrrolidines with activity as ubiquitin-specific peptidase inhibitors 30
ZA2022/13866A ZA202213866B (en) 2020-06-04 2022-12-21 N-cyanopyrrolidines with activity as usp30 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2101935.1A GB202101935D0 (en) 2021-02-11 2021-02-11 Novel compounds

Publications (1)

Publication Number Publication Date
GB202101935D0 true GB202101935D0 (en) 2021-03-31

Family

ID=75338904

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2101935.1A Ceased GB202101935D0 (en) 2020-06-04 2021-02-11 Novel compounds

Country Status (1)

Country Link
GB (1) GB202101935D0 (en)

Similar Documents

Publication Publication Date Title
GB2605894B (en) Novel compounds
GB202008749D0 (en) Novel compounds
GB202101734D0 (en) Novel Compounds
GB202115158D0 (en) Novel compounds
GB202016800D0 (en) Novel compounds
GB202014341D0 (en) Novel compounds
GB202013728D0 (en) Novel compounds
GB202409732D0 (en) Novel compounds
IL312389A (en) Novel benzyltryptamine compounds
GB202118096D0 (en) Novel compounds
GB202117366D0 (en) Novel compounds
GB202115150D0 (en) Novel compounds
GB202115156D0 (en) Novel compounds
GB202113016D0 (en) Novel compounds
GB202110809D0 (en) Novel compounds
GB202109446D0 (en) Novel compounds
GB202108873D0 (en) Novel compounds
GB202106871D0 (en) Novel compounds
GB202106872D0 (en) Novel compounds
GB202101935D0 (en) Novel compounds
GB202101573D0 (en) Novel compounds
GB202101280D0 (en) Novel compounds
GB202019590D0 (en) Novel Compounds
GB202019588D0 (en) Novel Compounds
GB202016785D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)